[1] |
Amir, R.E., Van den Veyver, I.B., Wan, M. et al. Nat. Genet., 23 (1999),pp. 185-188
|
[2] |
Ausió, J., de Paz, A.M., Esteller, M. MeCP2: the long trip from a chromatin protein to neurological disorders Trends Mol. Med., 20 (2014),pp. 487-498
|
[3] |
Chahrour, M., Jung, S.Y., Shaw, C. et al. MeCP2, a key contributor to neurological disease, activates and represses transcription Science, 320 (2008),pp. 1224-1229
|
[4] |
Cheng, T.L., Wang, Z., Liao, Q. et al. MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8/Drosha complex Dev. Cell, 28 (2014),pp. 547-560
|
[5] |
Collins, A.L., Levenson, J.M., Vilaythong, A.P. et al. Hum. Mol. Genet., 13 (2004),pp. 2679-2689
|
[6] |
Esteller, M. Non-coding RNAs in human disease Nat. Rev. Genet., 12 (2011),pp. 861-874
|
[7] |
Gecz, J., Baker, E., Donnelly, A. et al. Fibroblast growth factor homologous factor 2 (FHF2): gene structure, expression and mapping to the Borjeson-Forssman-Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS-like patient Hum. Genet., 104 (1999),pp. 56-63
|
[8] |
Goffin, D., Allen, M., Zhang, L. et al. Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses Nat. Neurosci., 15 (2012),pp. 274-283
|
[9] |
Goffin, D., Brodkin, E.S., Blendy, J.A. et al. Cellular origins of auditory event-related potential deficits in Rett syndrome Nat. Neurosci., 17 (2014),pp. 804-806
|
[10] |
Goldfarb, M. Fibroblast growth factor homologous factors: evolution, structure, and function Cytokine Growth Factor Rev., 16 (2005),pp. 215-220
|
[11] |
Guy, J., Cheval, H., Selfridge, J. et al. The role of MeCP2 in the brain Annu. Rev. Cell Dev. Biol., 27 (2011),pp. 631-652
|
[12] |
Guy, J., Hendrich, B., Holmes, M. et al. Nat. Genet., 27 (2001),pp. 322-326
|
[13] |
Lyu, J.W., Yuan, B., Cheng, T.L. et al. Sci. Rep., 6 (2016)
|
[14] |
Nan, X.S., Campoy, F.J., Bird, A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin Cell, 88 (1997),pp. 471-481
|
[15] |
Puranam, R.S., He, X.P., Yao, L. et al. J. Neurosci., 35 (2015),pp. 8866-8881
|
[16] |
Ramocki, M.B., Peters, S.U., Tavyev, Y.J. et al. Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome Ann. Neurol., 66 (2009),pp. 771-782
|
[17] |
Samaco, R.C., Mandel-Brehm, C., McGraw, C.M. et al. Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome Nat. Genet., 44 (2012),pp. 206-211
|
[18] |
Shahbazian, M.D., Antalffy, B., Armstrong, D.L. et al. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation Hum. Mol. Genet., 11 (2002),pp. 115-124
|
[19] |
Smallwood, P.M., Munoz-Sanjuan, I., Tong, P. et al. Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development Proc. Natl. Acad. Sci. U. S. A., 93 (1996),pp. 9850-9857
|
[20] |
Wu, Q.F., Yang, L., Li, S. et al. Fibroblast growth factor 13 is a microtubule-stabilizing protein regulating neuronal polarization and migration Cell, 149 (2012),pp. 1549-1564
|